Scholar Rock to Develop Cancer Immunotherapy Product Candidate, SRK-181, a Selective Inhibitor of TGFβ1 Activation, to Overcome Checkpoint Inhibitor Resistance

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition